Legal Opinion
Abbott Laboratories v. Geneva Pharmaceuticals, Inc., and Novopharm Limited, and Invamed, Inc.
Court of Appeals for the Federal Circuit
Decided August 5, 1999No. 98-1593 to 98-1595PublishedCited by 34 opinions
1Opinion of the Court
DECISION
LOURIE, Circuit Judge.
Abbott Laboratories appeals from the summary judgment of the United States District Court for the Northern District of Illinois holding claim 4 of its United States Patent 5,504,207 invalid under the on-sale provision of 35 U.S.C. § 102(b) (1994). See Abbott Labs. v. Geneva Pharms., Inc., 1998 WL 566884, Nos. 96 C 3331, 96 C 5868, 97 C 7587 (N.D.Ill. Sept. 1, 1998). Because we conclude that the district court properly granted summary judgment of invalidity, we affirm.
BACKGROUND
Terazosin hydrochloride is a pharmaceutical compound used for the treatment of…
2Cases cited10 opinions
- Eibel Process Co. v. Minnesota & Ontario Paper Co.Supreme Court of the United States · 1923
- Pfaff v. Wells Electronics, Inc.Supreme Court of the United States · 1998
- Robert Conroy v. Reebok International, Ltd.Court of Appeals for the Federal Circuit · 1994
- Tilghman v. ProctorSupreme Court of the United States · 1881
- Corona Cord Tire Co. v. Dovan Chemical Corp.Supreme Court of the United States · 1928
5 more not listed; retrieve them via the Exa API.
3Cited by34 opinions
- Dayco Products, Inc. v. Total Containment, Inc.Court of Appeals for the Federal Circuit · 2003
- Cargill, Inc. v. Canbra Foods, Ltd.Court of Appeals for the Federal Circuit · 2007
- Mylan Pharmaceuticals, Inc. v. ShalalaDistrict Court, District of Columbia · 2000
- Alexey T. Zacharin v. United StatesCourt of Appeals for the Federal Circuit · 2000
- SmithKline Beecham Corp. v. Apotex Corp.District Court, N.D. Illinois · 2003
29 more not listed; retrieve them via the Exa API.